Beibei Wang
Impact in
- Immunology top 5%
- Immune cells in cancer
- Neutrophil, Myeloperoxidase and Oxidative Mechanisms
- Immune Cell Function and Interaction
- Immune Response and Inflammation
- Immunotherapy and Immune Responses
- T-cell and B-cell Immunology
- Virology top 10%
Papers in
- Immunology 34
- Immunotherapy and Immune Responses 9
- Immune cells in cancer 9
- Immune Cell Function and Interaction 7
- T-cell and B-cell Immunology 6
- Immune Response and Inflammation 6
- Atherosclerosis and Cardiovascular Diseases 4
Beibei Wang
76 papers receiving 1.5k citations
Peers
Comparison fields: 5 of 120
- Immunology 632
- Virology 53
- Oncology 297
- Cancer Research 116
- Molecular Biology 478
Countries citing papers authored by Beibei Wang
This map shows the geographic impact of Beibei Wang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Beibei Wang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Beibei Wang more than expected).
Fields of papers citing papers by Beibei Wang
This network shows the impact of papers produced by Beibei Wang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Beibei Wang. The network helps show where Beibei Wang may publish in the future.
Co-authors
The 25 scholars most cited alongside Beibei Wang, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 2025 | 2 | |
| 2 | 2025 | 0 | |
| 3 | 2024 | 1 | |
| 4 | 2024 | 7 | |
| 5 | 2024 | 0 | |
| 6 | 2023 | 4 | |
| 7 | 2023 | 0 | |
| 8 | 2023 | 0 | |
| 9 | 2022 | 8 | |
| 10 | 2022 | 7 | |
| 11 | 2021 | 81 | |
| 12 | 2019 | 74 | |
| 13 | 2019 | 17 | |
| 14 | 2017 | 14 | |
| 15 | Anti-fatigue properties of icariin from Epimedium brevicornum | 2014 | 3 |
| 16 | 2014 | 3 | |
| 17 | 2013 | 24 | |
| 18 | 2012 | 12 | |
| 19 | Clinicopathological Significance of VEGF-C, VEGFR-3 and Cyclooxygenase-2 in Early-Stage Cervical Cancer. | 2008 | 5 |
| 20 | 2008 | 8 |
About Beibei Wang
Beibei Wang is a scholar working on Immunology, Rehabilitation, Aging, Genetics and Immunology and Allergy, having authored 83 papers that have together received 1.5k indexed citations. Recurring topics across this work include Immunotherapy and Immune Responses (9 papers), Immune cells in cancer (9 papers), Immune Cell Function and Interaction (7 papers), T-cell and B-cell Immunology (6 papers), Immune Response and Inflammation (6 papers), Ocular Diseases and Behçet’s Syndrome (4 papers), Atherosclerosis and Cardiovascular Diseases (4 papers) and Cytomegalovirus and herpesvirus research (4 papers). The work is most often cited by research in Immunology (632 citations), Virology (53 citations), Oncology (297 citations), Cancer Research (116 citations) and Molecular Biology (478 citations). Beibei Wang has collaborated with scholars based in China, United States and United Kingdom. Frequent co-authors include Hui Zeng, Yaxian Kong, Xingwang Xie, Henghui Zhang, Lai Wei, Junyan Han, Gaixia He, Yanhui Chen, Xueyan Wang and Hongsong Chen. Their work appears in journals such as Frontiers in Immunology, European Journal of Pharmacology, Circulation, The Journal of Infectious Diseases and Clinical & Experimental Immunology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.